STAT Plus: In a message to pharma, one-fifth of AbbVie shareholders support proposal tying pricing risks to exec pay

The drug-pricing issue has put the entire industry on the defensive.

More From BioPortfolio on "STAT Plus: In a message to pharma, one-fifth of AbbVie shareholders support proposal tying pricing risks to exec pay"